View Online
December 19th, 2019
It's so easy to renew your ABC membership for 2020!
If you haven't yet renewed, click here now.
News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.
Long-Term Cholesterol Risk Points to Need for Earlier Testing
New data from almost 400,000 individuals who were followed for up to 43 years have shown that the link between raised non-HDL cholesterol and future risk of cardiovascular disease is strongest in younger people.
Intermittent Fasting Promotes Weight Loss, Improves Lipids
Limiting food consumption to a 10-hour window each day promotes weight loss and improves cardiometabolic abnormalities in women with metabolic syndrome, a small pilot study suggests.
Cath Lab Exercise Test Flags Coronary Microvascular Dysfunction
In patients with angina but no obstructive coronary artery disease (CAD), low coronary flow reserve (CFR) detected in the cath lab can provide a clear diagnosis of coronary microvascular dysfunction (CMD), researchers report.
VIDEO: Superiority of Surgery vs Stents for Long-Term Mortality in Patients With Left Main Disease 'Unarguable'

Dr. John Mondrola from and Medscape Cardiology sits down to speak with Prof. John McMurray from Glasgow, Scotland at the 2019 American Heart Association meeting to discuss the EXCEL trial.
Your Dedication is Vital in 2020....Become a Member or
Renew Your ABC Membership Today!

It is time to renew your membership investment in the Association of Black Cardiologists (ABC). THANK YOU for your support and continuing participation. We recognize that the strength and success of our organization stems from the experience, dedication and commitment of our members. Without you we cannot continue the mission to achieve health equity through the elimination of disparities in cardiovascular care and outcomes!

Click here to join/renew online or remit payment by mail to Association of Black Cardiologists, Inc. - 2400 N Street, NW, Suite 200, Washington, DC 20037.

Please reaffirm your commitment to ABC’s vital work by renewing your membership today!

Consider Life Membership for $5,250 payable over three years. For more information, contact Katrese Phelps McCullum today to setup your payment plan.
Items of Interest
Appeals Court Upholds Decision Invalidating ACA's Individual Mandate
A federal appeals court this week upheld a lower-court ruling that the Affordable Care Act's (ACA) individual mandate is unconstitutional, but told the district judge in the case to look again at whether other parts of the law can still stand.
FDA Approves Icosapent Ethyl to Reduce CV Risk
The FDA has approved Amarin’s Vascepa—icosapent ethyl—to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk patients, making it the first drug of its kind to be approved in the U.S. Amarin announced the expanded indication and label for Vascepa on Dec. 13, noting that after “more than a decade of development and testing,” its icosapent ethyl capsules are the first and only solution approved as an adjunct to maximally tolerated statin therapy to reduce the risk of MI, stroke, unstable angina and coronary revascularization in patients with elevated triglycerides and established CVD. The company estimates that millions of high-risk patients in the U.S. could benefit from the therapy.
PODCAST: Big Stories in Cardiology Research 2019 with Clyde Yancy, MD and Donald Lloyd-Jones, MD
Of the thousands of studies published by Northwestern scientists in 2019, some of the most discussed came from the field of cardiology. Two Northwestern physician scientists, Dr. Clyde Yancy and Dr. Donald Lloyd-Jones, review some of these findings and share their thoughts on advances in cardiology to come in 2020.
Janssen Reimagines Digital Clinical Trial Design With CHIEF-HF
Known as Canagliflozin: Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF), the trial is a completely decentralised, mobile, indication-seeking clinical study. It will involve a population of patients with heart failure, with or without type 2 diabetes. It is expected to use personal smartphones and wearable devices to track participants, with no in-person clinical visits required. It will also include an individualised patient-centric outlook. The study will enable Janssen to use technology to make traditional healthcare models more patient-centric and cost-effective.
Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.
Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial
Co-authored by Renee P. Bullock-Palmer, MD (with Angela Lowenstern, MD; Karen P. Alexander, MD; C. Larry Hill, PhD; Brooke Alhanti, PhD; Patricia A. Pellikka, MD; Michael G. Nanna, MD; Rajendra H. Mehta, MD; Lawton S. Cooper, MD; et al.)
Although cardiovascular (CV) disease represents the leading cause of morbidity and mortality that increases with age, the best noninvasive test to identify older patients at risk for CV events remains unknown. This study sought to determine whether the prognostic utility of anatomic vs functional testing varies based on patient age.
The Yoga-Meditation Heart Connection: A Pilot Study Looking to Improve Women's Heart Health
Co-authored by Rachel Bond (with Sasha De Jesus and Emily Schultz)
Stress, anxiety, and depression are nontraditional risk factors for cardiovascular disease (CVD) that are more common in women. Although there is limited understanding of the mechanism behind its benefit, measures such as yoga and meditation may decrease morbidity in patients with CVD. With this in mind, we hypothesize that regular, supervised sessions of chair yoga and meditation can be a complementary measure to decrease the level of anxiety, stress and depression in female patients with or at risk for CVD, as well as increase their likelihood to pursue lifestyle modifications.

We LOVE to LEARN how our ABC Members are making a difference! Please Share. Giving a keynote speech? Presenting at a Grand Round? Receiving an Award? Interviewed by the Press? Published in a journal? Presenter or Panelist at a Conference? Graduating? Email Rachel Williams at or please tag or DM us on Facebook, Twitter or Instagram with links/details, so we can spotlight your excellence in our newsletter!

Upcoming Events
Know Diabetes by Heart: Management of
Type 2 Diabetes and Hypertension

Thursday, January 30, 2020 | 12:00p – 1:00p ET

Hypertension is common among patients with diabetes and is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. The American Heart Association, the American Diabetes Association and the Association of Black Cardiologists have partnered together to discuss the Management of T2D and Hypertension.

Join Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA, Professor of Clinical Medicine at the Tulane University Heart and Vascular Institute and Ian de Boer, MD, MS, Associate Professor of Medicine, Division of Nephrology Adjunct Associate Professor, Epidemiology at the University of Washington as they review current guidelines, barriers in hypertension and diabetes management, and clinical solutions to reduce those barriers.

To ask your question during the live event dial: 855-859-7303


MEDICAL STUDENTS and NURSES: First 50 registrants are FREE
Public invited free for the SUNDAY MORNING session.
Space is limited, must pre-register.

This email was sent to ##email## by Association of Black Cardiologists, powered by Powered by Multiview's Content Marketing
Archive | View Online | Unsubscribe | Subscribe